For decades, coffee carried a quiet reputation as something to limit "for your heart." That reputation is, by current evidence, no longer accurate.
A landmark umbrella review in The BMJ, which pulled together more than 200 meta-analyses on coffee consumption, concluded that drinking three to four cups a day was associated with about a 17% reduction in all-cause mortality and a 19% reduction in cardiovascular mortality compared with no coffee at all. The benefit appeared to peak around that intake range, and it held across most populations studied. A later analysis of about 450,000 adults in the UK Biobank reinforced the picture, finding that two to three cups daily — ground, instant, or decaf — was tied to lower rates of cardiovascular disease, arrhythmia, and overall mortality.
Tea tells a quieter, parallel story. A prospective study of nearly half a million UK adults found that drinking two or more cups of tea a day was associated with a 9 to 13% reduction in all-cause mortality compared with non-tea-drinkers, with the benefit appearing regardless of how quickly people's bodies metabolized caffeine. In Japan, the long-running Ohsaki Study followed more than 40,000 adults and found that those drinking five or more cups of green tea a day had meaningfully lower cardiovascular and all-cause mortality, particularly among women.
The Filter Question and the LDL Footnote
The mechanisms differ. Coffee's chlorogenic acids appear to support blood vessel function and glucose regulation. Tea's catechins and theaflavins are linked to better cholesterol profiles and lower blood pressure in some trials. Both contribute to what nutrition researchers tend to call a protective dietary pattern: not a single magic compound, but a steady contribution to overall vascular health.
There is one caveat worth knowing about coffee specifically. Unfiltered preparations — French press, espresso, percolated, and traditional boiled or Scandinavian-style — contain compounds called cafestol and kahweol, which can modestly raise LDL cholesterol. A paper filter strips most of them out. If cholesterol management is a priority, drip and pour-over methods avoid that particular trade-off.
Coffee also stands out for its remarkably consistent association with lower type 2 diabetes risk. A dose-response meta-analysis covering more than 1.1 million adults concluded that each additional daily cup was associated with about a 9% lower risk of developing the disease — and notably, the protective effect appeared with both regular and decaffeinated coffee, which suggests the active ingredient is something other than caffeine.